Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts

Journal of Bone and Mineral Research

Volumn 20, Issue 11, 2005, Pages 2036-2043

  Viereck, Volker ^a   Gründker, Carsten ^a   Friess, Stephanie C ^a   Frosch, Karl Heinz ^a   Raddatz, Dirk ^a   Schoppet, Michael ^b   Nisslein, Thomas ^c   Emons, Günter ^a   Hofbauer, Lorenz C ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Schaper & Brummer GmbH & Co KG   (Germany)

Author keywords

Black cohosh; Osteoblastic differentiation; Osteoblasts; Osteoprotegerin

Indexed keywords

2 PROPANOL; ALKALINE PHOSPHATASE; ANTIESTROGEN; BIOLOGICAL MARKER; CIMICIFUGA RACEMOSA EXTRACT; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; HERBACEOUS AGENT; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ACTAEA; ADULT; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN THERAPY; FEMALE; HUMAN; MALE; MENOPAUSAL SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; POSTMENOPAUSE OSTEOPOROSIS; PROTECTION; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHIZOME; STEADY STATE; STIMULATION; THROMBOEMBOLISM;

2-PROPANOL; ADULT; ALKALINE PHOSPHATASE; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CIMICIFUGA; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MENOPAUSE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PLANT EXTRACTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PROGESTERONE; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 27444438388     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050716     Document Type: Article

References (34)

1. Fitzpatrick LA 1999 Selective estrogen receptor modulators and phytoestrogens: New therapies for the postmenopausal women. Mayo Clin Proc 74:601-607.
2. Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S, and the Canadian Task Force on Preventive Health Care 2004 Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 170:1665-1667.
3. Viereck V, Emons G, Wuttke W 2005 Black cohosh-just another phytoestrogen? Trends Endocrinol Metab 16:214-221.
4. Nisslein T, Freudenstein J 2003 Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab 21:370-376.
5. Seidlová-Wuttke D, Jarry H, Pitzel L, Wuttke W 2005 Effects of estradiol-17β, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats. Maturitas 51:177-186.
6. Seidlová-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W 2003 Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: Bone, fat and uterus. Maturitas 44(Suppl 1):S39-S50.
7. Wuttke W, Seidlová-Wuttke D, Gorkow C 2003 The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: Effects on menopause symptoms and bone markers. Maturitas 44(Suppl 1):S67-S77.
8. Oursler MJ, Landers JP, Riggs BL, Spelsberg TC 1993 Oestrogen effects on osteoblasts and osteoclasts. Ann Med 25:361-371.
9. Braidman IP, Hainey L, Batra G, Selby PL, Saunders PT, Hoyland JA 2001 Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res 16:214-220.
10. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S 1999 The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819-828.
11. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang M-S, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Eliott R, Colombero A, Tan H-L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen EST, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
12. Yasuda H, Shima N, Nakagawa N, Mochizuki S-I, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
13. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian Y-X, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
14. Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:1504-1508.
15. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL 1999 Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367-4370.
16. Viereck V, Gründker C, Blaschke S, Siggelkow H, Emons G, Hofbauer LC 2002 Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84:725-735.
17. Viereck V, Gründker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch KH, Raddatz D, Emons G, Hofbauer LC 2003 Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. J Clin Endocrinol Metab 88:4206-4213.
18. Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hüfner M 1999 Developmental of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 75:22-35.
19. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389.
20. Raddatz D, Middel P, Bockemuhl M, Benohr P, Wissmann C, Schworer H, Ramadori G 2004 Glucocorticoid receptor expression in inflammatory bowel disease: Evidence for a mucosal down-regulation in steroid-unresponsive ulcerative colitis. Aliment Pharmacol Ther 19:47-61.
21. 3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC3T3) and growth cartilage cells in culture. J Biol Chem 264:11879-11886.
22. Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gründker C, Hofbauer LC 2002 Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291:680-686.
23. Burguera B, Hofbauer LC, Thomas T, Gori F, Evans GL, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:3546-3553.
24. Pfeilschifter J, Koditz R, Pfohl M, Schatz H 2002 Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23:90-119.
25. Felson DT, Zhang Y, Hannman MT, Kiel DP, Wilson PW, Anderson JJ 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141-1146.
26. Anderson JJ, Garner SC 1998 Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12:543-557.
27. World Health Organization 2003 Breast cancer. In: Steward BW, Kleihues P (eds.) World Cancer Report. IARC Press, Lyon, France, pp. 188-193.
28. Jarry H, Harnischfeger G, Düker E 1985 The endocrine effects of constituents of Cimicifuga racemosa. 2. In vitro binding of constituents to estrogen receptors. Planta Med 51:316-319.
29. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W 2003 In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 44:S31-S38.
30. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R 2004 Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res Treat 84:151-160.
31. Hostanska K, Nisslein T, Freudenstein J, Reichling J, Saller R 2004 Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells. Biol Pharm Bull 27:1970-1975.
32. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA 2004 Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest 22:515-521.
33. Ireland DC, Bord S, Beavan SR, Compston JE 2003 The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32:136-141.
34. Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB, Farnsworth NR, Bolton JL 2003 Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agricult Food Chem 51:5661-5670.